Up-regulation of VEGF expression and related neo-angiogenesis in childhood high-grade gliomas: Implications for anti-angiogenic anti-neoplastic therapy

In Vivo

Volumn 20, Issue 4, 2006, Pages 511-518

  Bodey, Bela ^a,b,d   Siegel, Stuart E ^b   Kaiser, Hans E ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c International Society for the Study of Comparative Oncology ISSCO   (United States)

^d NONE   (United States)

Author keywords

Anaplastic astrocytoma (AA); Astrocytoma (ASTR); Glioblastoma multiforme (GBM); Immunohistochemistry; Immunophenotype (IP); Monoclonal antibody (MoAB); Neoangiogenesis; Neoplastic transformation; Vascular endothelial growth factor (VEGF)

Indexed keywords

ALKALINE PHOSPHATASE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; VASCULOTROPIN 121;

ANGIOGENESIS; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER PATIENT; CANCER TISSUE; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CHILDHOOD CANCER; CONTROLLED STUDY; CYTOPLASM; DRUG DESIGN; DRUG TARGETING; EMBRYO CELL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; MOLECULAR BIOLOGY; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; TISSUE DISTRIBUTION; TREATMENT PLANNING; TUMOR CELL; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; UPREGULATION;

EID: 33746911513     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Williams BP, Abney ER and Raff MC: Macroglial cell development in embryonic rat brain: studies using monoclonal antibodies, flourescence-activated cell sorting and cell culture. Dev Biol 112: 126-134, 1985.
2. von Deimling A, Louis DN and Wiestler OD: Molecular pathways in the formation of gliomas. Glia 15: 328-338, 1995.
3. Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW and Burger PC: Histopathology, classification, and grading of gliomas. Glia 15: 211-221, 1995.
4. Bodey B, Bodey B Jr and Siegel SE: Immunophenotypical (IP) differential diagnosis and immunobiology of childhood primary brain tumors. A decade of experience. Int J Pediatric Hematol/Oncol 6: 65-84, 1998.
5. Children's Cancer Research Fund: http://www.children scancer.org/research_archive5.jhtml
6. Jemal A, Myrray T, Samuels A, Ghafoor A, Ward E and Thun MJ: Cancer Statistics, 2003. CA Cancer J Clin 53: 5-26, 2003.
7. Katsura S, Suzuki J and Wada T: Statistical study of brain tumours in the neurosurgical clinics in Japan. J Neurosurg 16: 570-580, 1959.
8. Torres LF, Jacob GV, Reis-Filho JS and de Noronha L: Primary pediatric tumours of the central nervous system. Anatomopathological study of 623 cases. Arq Neuropsiquiatr 55: 795-800, 1997.
9. Plate KH, Breier G, Weich HA and Risau W: Vascular endothelial growth factor and glioma angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.
10. Falchetti ML, Pierconti F, Casalbore P, Maggiano N, Levi A, Larocca LM and Pallini R: Glioblastoma induces vascular endothelial cells to express telomerase in vitro. Cancer Res 63: 3750-3754, 2003.
11. Russel DS and Rubinstein LJ: Pathology of Tumors of the Nervous System. Baltimore, Williams & Wilkins, erd Ed., pp. 83-350, 1989.
12. Zagzag D: Angiogenic growth factors in neural embryogenesis and neoplasia. Am J Pathol 146: 293-309, 1995.
13. Bouck N: Angiogenesis: a mechanism by which oncogenes and tumor suppressor genes regulate tumorigenesis. Cancer Treat Res 63: 359-371, 1992.
14. Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S and Nose T: Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56: 2185-2190, 1996.
15. Cheung N, Wong MP, Yuen ST, Leung SY and Chung LP: Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon. Hum Pathol 29: 910-914, 1998.
16. Sharkey AM, Charnock-Jones DS, Boocock CA, Brown KD and Smith SK: Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil 99: 609-615, 1993.
17. Aase K, Lymboussaki A, Kaipainen A, Olofsson B, Alitalo K and Eriksson U: Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature. Dev Dyn 215: 12-25, 1999.
18. Zulch KJ and Wechsler W: Pathology and classification of gliomas. Progr Neurol Surg, Vol. 2, Karger, Basel-New York, pp. 1-84, 1968.
19. Zulch KJ: Histologic classification of tumours of the central nervous system. International Histological Classification of Tumours, No. 21, World Health Organization, Geneva, 1979.
20. Zulch KJ: Principles of the new World Health Organization (WHO) classification of brain tumors. Neuroradiology 19: 59-66, 1980.
21. Szymas J: Histologic classification of central nervous system tumors by the World Health Organization. Pol J Pathol 45: 81-91, 1994.
22. Szymas J: Diagnostic immunohistochemistry of tumors of the central nervous system. Folia Neuropathol 32: 209-214, 1994.
23. Janckila AJ, Yam LT and Li C-Y: Immunoalkaline phosphatase cytochemistry. Am J Clin Pathol 84: 476-480, 1985.
24. Cattoretti G, Berti E, Schiro R, D' Amato L, Valeggio C and Rilke F: Improved avidin-biotin-peroxidase complex (ABC) staining. Histol J 20: 75-80, 1988.
25. Yam LT, Janckila AJ, Epremian BE and Li C-Y: Diagnostic significance of levamisole-resistant alkaline phosphatase in cytochemistry and immunocytochemistry. Am J Clin Pathol 91: 31-36, 1989.
26. Strasburger CJ, Amir-Zaltsman Y and Kohen F: The avidin-biotin reaction as an universal amplification system in immunoassays. Prog Clin Biol Res 285: 79-100, 1988.
27. Wilchek M and Bayer EA: Introduction to avidin-biotin technology. Methods Enzymol 184: 5-13, 1990.
28. Duhamel RC and Whitehead JS: Prevention of nonspecific binding of avidin. Methods Enzymol 184: 201-207, 1990.
29. Diamandis EP and Christopoulos TK: The biotin-(strept)avidin system: principles and applications in biotechnology. Clin Chem 37: 625-636, 1991.
30. Hsu SM, Raine L and Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison of ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 29: 577-581, 1981.
31. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Immunocytochemical Detection of the Homeobox B3, B4, and C6 Gene Products in Childhood Medulloblastomas/Primitive Neuroectodermal Tumors. Anticancer Res 20: 1769-1780, 2000.
32. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Fas (APO-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells? In Vivo 13: 357-373, 1999.
33. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Fas (APO-1, CD95) receptor expression and new options of immunotherapy in childhood medulloblastomas. Anticancer Res 19: 3293-3314, 1999.
34. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors. In Vivo 14: 667-673, 2000.
35. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line-derived counterparts. In Vivo 14: 675-682, 2000.
36. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Matrix metalloproteinase expression in childhood astrocytomas. Anticancer Res 20: 3287-3292, 2000.
37. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Immunocytochemical detection of leukocyte-associated and apoptosis-related antigen expression in childhood brain tumors. Crit Rev Oncology/Hemat 39: 3-16, 2001.
38. Bodey B: The significance of immunocytochemistry in the diagnosis and therapy of neoplasms. Exp Opin Biol Ther 2: 371-393, 2002.
39. Bodey B, Siegel SE and Kaiser HE: MAGE-1, a cancer-testis Antigen, expression in childhood astrocytomas as an indicator of tumor progression. In Vivo 16: 583-588, 2002.
40. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas. Anticancer Res 21: 2021-2028, 2001.
41. Bodey B, Bodey B Jr, Groger AM, Siegel SE and Kaiser HE: Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung. In Vivo 15: 175-180, 2001.
42. Bodey B, Siegel SE and Kaiser HE: Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas. In Vivo 15: 71-76, 2001.
43. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis. In Vivo 15: 57-64, 2001.
44. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas. In Vivo 14: 659-666, 2000.
45. Battifora H: The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest 55: 244-248, 1986.
46. Battifora H and Mehta P: The checkerboard tissue block. An improved multitissue control block. Lab Invest 63: 722-724, 1990.
47. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M and Fukui M: Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55: 1189-1193, 1995.
48. Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU and Oldfield EH: Expression of the vascular permeability factor /vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91: 153-159, 1993.
49. Morii K, Tanaka R, Washiyama K, Kumanishi T and Kuwano R: Expression of vascular endothelial growth factor in capillary hemangioblastoma. Biochem Biophys Res Commun 194: 749-755, 1993.
50. Wizigmann-Voos S, Breier G, Risau W and Plate KH: Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55: 1358-1364, 1995.
51. Plate KH, Breier G, Weich HA, Mennel HD and Risau W: Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59: 520-529, 1994.
52. Breier G, Albrecht U, Sterrer S and Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114: 521-532, 1992.
53. Risau W: Embryonic angiogenesis factors. Pharmacol Ther 51: 371-376, 1991.
54. Risau W: Molecular biology of blood-brain barrier onto-genesis and function. Acta Neurochir (Wien) [Suppl] 60: 109-112, 1994.
55. Shim JW, Koh YC, Ahn HK, Park YE, Hwang DY and Chi JG: Expression of bFGF and VEGF in brain astrocytoma. J Korean Med Sci 11: 149-157, 1996.
56. Melnyk O, Shuman MA and Kim KJ: Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res 56: 921-924, 1996.
57. Machein MR, Kullmer J, Fiebich BL, Plate KH and Warnke PC: Vascular endothelial growth factor expression, vascular volume, and, capillary permeability in human brain tumors. Neurosurgery 44: 732-740. discussion 740-741, 1999.
58. Gesundheit B, Klement G, Senger C, Kerbel R, Kieran M, Baruchel S and Becker L: Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood. Med Pediatr Oncol 41: 516-526, 2003.
59. Bian XW, Jiang XF, Chen JH, Bai JS, Dai C, Wang QL, Lu JY, Zhao W, Xin R, Liu MY, Shi JQ and Wang JM: Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas. Int Immunopharmacol 6: 90-99, 2006.
60. Munaut C, Noel A, Hougrand O, Foidart JM, Boniver J and Deprez M: Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int J Cancer 106: 848-855, 2003.
61. Repovic P, Fears CY, Gladson CL and Benveniste EN: Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells. Oncogene 22: 8117-8124, 2003.
62. Birner P, Piribauer M, Fischer I, Gatterbauer B, Marosi C, Ambros PF, Ambros IM, Bredel M, Oberhuber G, Rossler K, Budka H, Harris AL and Hainfellner JA: Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes. Brain Pathol 13: 133-143, 2003.
63. Huang H, Held-Feindt J, Buhl R, Mehdorn HM and Mentlein R: Expression of VEGF and its receptors in different brain tumors. Neurol Res 27: 371-377, 2005.
64. Hovinga KE, Stalpers LJ, van Bree C, Donker M, Verhoeff JJ, Rodermond HM, Bosch DA and van Furth WR: Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines - a clue to radioresistance? J Neurooncol 74: 99-103, 2005.
65. Folkman J: Fighting cancer by attacking its blood supply. Sci Am 275: 150-154, 1996.
66. Folkman J: New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 32A: 2534-2539, 1996.